DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
PF-03654746 is an investigational drug.
There have been 6 clinical trials for PF-03654746. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2007.
The most common disease conditions in clinical trials are Hyperkinesis, Tourette Syndrome, and Disease. The leading clinical trial sponsors are Pfizer, Yale University, and [disabled in preview].
Recent Clinical Trials for PF-03654746
|Study Evaluating The Safety And Efficacy Of PF-03654746 In Adult Subjects With Tourette's Syndrome||Pfizer||Phase 2|
|A Study to Evaluate the Safety, Tolerability, and Blood Levels of PF-03654746 in Subjects With Mild to Moderate Alzheimer's Disease||Pfizer||Phase 1|
|A Study Of A Novel Compound For Excessive Daytime Sleepiness Associated With Narcolepsy||Pfizer||Phase 2|